Literature DB >> 26954411

Association Between Hypertensive Disorders of Pregnancy and Later Risk of Cardiomyopathy.

Ida Behrens1, Saima Basit1, Jacob Alexander Lykke2, Mattis Flyvholm Ranthe1, Jan Wohlfahrt1, Henning Bundgaard3, Mads Melbye4, Heather A Boyd1.   

Abstract

IMPORTANCE: Women with hypertensive disorders of pregnancy, preeclampsia in particular, have an increased risk of cardiomyopathy during the peripartum period. Whether hypertensive disorders of pregnancy are also associated with cardiomyopathy later in life is unknown.
OBJECTIVE: To determine whether hypertensive disorders of pregnancy are associated with cardiomyopathy beyond the peripartum period. DESIGN, SETTING, AND PARTICIPANTS: Nationwide register-based cohort study using Cox regression to compare rates of cardiomyopathy in women with and without a history of hypertensive disorders of pregnancy in a cohort of 1,075,763 women with at least 1 pregnancy ending in live birth or stillbirth in Denmark, 1978-2012, with follow-up through December 31, 2012. EXPOSURES: A hypertensive disorder of pregnancy (severe or moderate preeclampsia or gestational hypertension) registered in the National Patient Register. MAIN OUTCOMES AND MEASURES: Cardiomyopathy more than 5 months after delivery (outside the peripartum period) up to 34 years 7 months. RESULT: The women in the primary cohort had 2,067,633 eligible pregnancies during the study period, 76,108 of which were complicated by a hypertensive disorder of pregnancy. During follow-up, 1577 women (mean age, 48.5 years at cardiomyopathy diagnosis; 2.6% with multiple pregnancies) developed cardiomyopathy. Compared with women with normotensive pregnancies (18,211,603 person-years of follow-up; n = 1408 cardiomyopathy events, 7.7/100,000 person-years [95% CI, 7.3-8.2]), women with a history of hypertensive disorders of pregnancy had significantly increased rates of cardiomyopathy (in 173,062 person-years of follow-up among women with severe preeclampsia, n = 27 cardiomyopathy events; 15.6/100,000 person-years [95% CI, 10.7-22.7]; adjusted hazard ratio [HR], 2.20 [95% CI, 1.50-3.23]; in 697,447 person-years of follow-up among women with moderate preeclampsia, n = 102 cardiomyopathy events; 14.6/100,000 person-years [95% CI, 12.0-17.8]; adjusted HR, 1.89 [95% CI, 1.55-2.23]; in 213,197 person-years of follow-up among women with gestational hypertension, n = 40 cardiomyopathy events; 17.3/100,000 person-years [95% CI, 12.7-23.6]; adjusted HR, 2.06 [95% CI, 1.50-2.82]). These increases persisted more than 5 years after the latest pregnancy. Mediation analyses suggested that only about 50% of the association was an indirect association through postpregnancy chronic hypertension. In this cohort, 11% of all cardiomyopathy events occurred in women with a history of hypertensive disorders of pregnancy. CONCLUSIONS AND RELEVANCE: Women with a history of hypertensive disorders of pregnancy, compared with women without such a history, had a small but statistically significant increased risk of cardiomyopathy more than 5 months after delivery. Further research is necessary to understand whether there is a causal mechanism behind this association.

Entities:  

Mesh:

Year:  2016        PMID: 26954411     DOI: 10.1001/jama.2016.1869

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  37 in total

1.  Acute Cardiac Effects of Severe Pre-Eclampsia.

Authors:  Arthur Jason Vaught; Lara C Kovell; Linda M Szymanski; Susan A Mayer; Sara M Seifert; Dhananjay Vaidya; Jamie D Murphy; Cynthia Argani; Anna O'Kelly; Sarah York; Pamela Ouyang; Monica Mukherjee; Sammy Zakaria
Journal:  J Am Coll Cardiol       Date:  2018-07-03       Impact factor: 24.094

2.  Nesfatin-1 Promotes Proliferation, Migration and Invasion of HTR-8/SVneo Trophoblast Cells and Inhibits Oxidative Stress via Activation of PI3K/AKT/mTOR and AKT/GSK3β Pathway.

Authors:  Tingting Li; Sumei Wei; Conghong Fan; Dongmei Tang; Dan Luo
Journal:  Reprod Sci       Date:  2020-09-24       Impact factor: 3.060

3.  Persistent cardiac dysfunction on echocardiography in African American women with severe preeclampsia.

Authors:  Lisa D Levine; Jennifer Lewey; Nathanael Koelper; Katheryne L Downes; Zolt Arany; Michal A Elovitz; Mary D Sammel; Bonnie Ky
Journal:  Pregnancy Hypertens       Date:  2019-05-30       Impact factor: 2.899

4.  Heart Failure in Women With Hypertensive Disorders of Pregnancy: Insights From the Cardiovascular Disease in Norway Project.

Authors:  Michael C Honigberg; Hilde Kristin Refvik Riise; Anne Kjersti Daltveit; Grethe S Tell; Gerhard Sulo; Jannicke Igland; Kari Klungsøyr; Nandita S Scott; Malissa J Wood; Pradeep Natarajan; Janet W Rich-Edwards
Journal:  Hypertension       Date:  2020-08-24       Impact factor: 10.190

5.  Hypertensive disorders in pregnancy.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-06

6.  Women's Cardiovascular Health After Hypertensive Pregnancy: The Long View From Labor and Delivery Becomes Clearer.

Authors:  Michael C Honigberg; Pradeep Natarajan
Journal:  J Am Coll Cardiol       Date:  2020-05-12       Impact factor: 24.094

Review 7.  Hypertensive Disorders of Pregnancy and Cardiovascular Diseases: Current Knowledge and Future Directions.

Authors:  Thais Coutinho; Olabimpe Lamai; Kara Nerenberg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-06-19

8.  Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy.

Authors:  Michael C Honigberg; Seyedeh Maryam Zekavat; Krishna Aragam; Derek Klarin; Deepak L Bhatt; Nandita S Scott; Gina M Peloso; Pradeep Natarajan
Journal:  J Am Coll Cardiol       Date:  2019-11-11       Impact factor: 24.094

9.  Risk of Preeclampsia and Pregnancy Complications in Women With a History of Acute Kidney Injury.

Authors:  Jessica Sheehan Tangren; Wan Ahmad Hafiz Wan Md Adnan; Camille E Powe; Jeffrey Ecker; Kate Bramham; Michelle A Hladunewich; Elizabeth Ankers; S Ananth Karumanchi; Ravi Thadhani
Journal:  Hypertension       Date:  2018-06-18       Impact factor: 10.190

Review 10.  Hypertensive Disorders of Pregnancy.

Authors:  Sahar Naderi; Sandra A Tsai; Abha Khandelwal
Journal:  Curr Atheroscler Rep       Date:  2017-03       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.